Chugai Pharmaceutical Co., Ltd. Web Site ... 07/30/2008 FDA Advisory Committee Votes in Favor to Recommend Approval of Actemra ®, a Humanized Anti-Human ...
Anti-HER2 humanized monoclonal antibody. Gastric cancer # Phase III Multinational study. R340. Colorectal cancer # Filed Feb.08. capecitabine Xeloda Oral. Roche
San Francisco, CA, USA) Multiple myeloma, non-Hodgkin lymphoma: Phase I : SK2: IgG1: Humanized: Mus musculus: IL-6: Chugai pharmaceuticals Co. Ltd. (Japan) / F.
Chugai Pharma USA LLC is a research-based, global pharmaceutical company that discovers ... MRA (tocilizumab) is a humanized monoclonal antibody against the human ...
Hoffmann-La Roche Ltd. announced today that the humanized anti-human IL-6 (interleukin-6 ... For more information, please visit www.chugai-pharm.co.jp. Contact:
... Chugai) 16-Apr-2008: OSI Pharmaceuticals ... Pharmaceuticals) 14-Dec-2007 "Actemra®," a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, Filed for Rheumatoid Arthritis in Europe (Chugai ...
Selection of therapeutic antibodies successfully humanized by ... Chugai Pharmaceuticals (Japan)
... Co., Ltd. announced today that bevacizumab (genetical recombination), a humanized anti ... For more information, please visit www.chugai-pharm.co.jp. Contact: Chugai Pharmaceutical ...
Get Chugai Pharmaceutical Co. Ltd. company research ... Avastin, a humanized anti- vascular endothelial growth ... 81 3 3273 0881. Fax: www.chugai-pharm.co.jp
Burns, CEO of the Pharmaceuticals Division at Roche. Actemra is the first humanized interleukin-6 (IL-6) receptor ... information is available on the Internet at www.chugai-pharm ...
Hoffmann-La Roche Ltd. announced today that the humanized anti-human IL-6 (interleukin-6 ... haemoglobin and albumin) associated with Castleman's disease." http://www.chugai-pharm.co.jp
Humanized anti-interlukin-6 receptor antibody treatment of multicentric Castlemans ... Chugai Pharmaceuticals 2-1-1,Nihonbashi-Muromachi Chuo-ku,Tokyo, Japan 104-8301
... reports on two major achievements in Japan, the world's second largest pharmaceuticals market Chugai ... Avastin ? a recombinant humanized therapeutic antibody - inhibits Vascular ...
humanized, recombinant: Rheumatoid Arthritis (Japan), systemic-onset Juvenile Idiopathic Arthritis (Japan) F.Hoffman-La Roche and Chugai Pharmaceuticals
Selection of humanized therapeutic antibody candidates ... Chugai Pharmaceuticals (Japan)
Get Chugai Pharmaceutical Co. Ltd. (4519.T) stock ... Avastin, a humanized anti- vascular endothelial growth ... www.chugai-pharm.co.jp
... companies from all over the world for over 18 years TAG has successfully humanized ... market approval for the treatment of multiple sclerosis and Actemra ® (Chugai Pharmaceuticals ...
Actemra is the first humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal ... Additional information is available on the Internet at http://www.chugai-pharm.co.jp.
For more information, please visit www.chugai-pharm.co.jp. About Taisho Pharmaceutical Co Ltd ... Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti ...
For more information, please visit www.chugai-pharm.co.jp. About Taisho Pharmaceutical Co ... Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti ...
... Co., Ltd. announced today that bevacizumab (genetical recombination), a humanized anti ... For more information, please visit www.chugai-pharm.co.jp. Contact: Chugai Pharmaceutical ...
... Co., Ltd. announced today that bevacizumab (genetical recombination), a humanized anti ... For more information, please visit www.chugai-pharm.co.jp. Contact: Chugai Pharmaceutical ...
For more information, please visit www.chugai-pharm.co.jp. About Taisho Pharmaceutical Co Ltd ... Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti ...
Chugai Pharma USA ... Humanized antibody against the IL-6 receptor. In Phase I ... Ariad Pharmaceuticals
For more information, please visit www.chugai-pharm.co.jp. Source: Chugai Pharmaceutical Co ... Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti ...
Chugai Pharma USA San Diego, CA. Phase II. after angioplasty : CAL (humanized anti-PTHrP MAb) none / none Cancer, Bone Mastastases. Chugai Pharma USA
For more information, please visit www.chugai-pharm.co.jp. About Taisho Pharmaceutical Co Ltd ... Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti ...
For more information, please visit www.chugai-pharm.co.jp. Contact: Chugai Pharmaceutical ... Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti ...
For more information, please visit www.chugai-pharm.co.jp. About Taisho Pharmaceutical Co Ltd ... Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti ...
For more information, please visit www.chugai-pharm.co.jp. Contact: Chugai Pharmaceutical ... Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti ...
|
|